Background Current guidelines prioritize the use of Azvudine in Coronavirus Disease 2019
(COVID-19) patients, while biomarkers for prognosis in Azvudine-treated COVID-19 patients …

During SARS-CoV-2 infection, eosinopenia may reflect a hyperactive immune response. In
this study of hospitalized COVID-19 patients, we aimed to better understand the prognostic …

Abstract Background Coronavirus disease 19 (COVID-19) has become a global
unprecedented pandemic infecting more than one millon people, which is declared by WHO …

Background Studies on the role of eosinophils in coronavirus disease 2019 (COVID-19) are
scarce, though available findings suggest a possible association with disease severity. Our …

Objectives A novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2), is causing the worldwide coronavirus disease 2019 (COVID-19) outbreak with high …

Abstract Keywords: coronavirus disease; COVID-19; eosinopenia; exacerbation; intensive
care unit; prognosis EN coronavirus disease COVID-19 eosinopenia exacerbation intensive …

Knowledge about the immune responses against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, particularly regarding the function of eosinophils, has …

Abstract Background and Aim Viral pneumonia is the most relevant clinical presentation of
COVID‐19 which may lead to severe acute respiratory syndrome and even death …

Introduction Eosinopenia has been observed during infection with the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of COVID‐19. This …

Abstract Background Admission eosinopenia (< 100 cells/μL) is associated with poor clinical
outcomes in hospitalized COVID-19 patients. However, the effects of eosinophil recovery …